OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved ...

Health care routinely recommends movement without providing assessment, dosage, progression, and follow-up that turn good ...

GLP-1 drugs first made their mark in diabetes and obesity, but many research efforts are underway to bring such therapies to more indications. Altimmune now has mid-stage clinical trial results ...

Earlier detection is valuable, but it creates a duty that does not end when an alert appears in the electronic health record.

City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The ...

Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah ...

Cybersecurity leaders discussed how AI-driven cybersecurity attacks pose a new level of risk for hospitals and health systems ...

HealthTap launched a virtual care program to support sleep equipment suppliers and patients using PAP therapy.

Happy Health has received FDA clearance for its wearable ring, which continuously measures blood pressure without a cuff or ...

Diagnostics and drug development startup Arboretum LifeSciences launched with $30 million in financing. Its executives say ...

The Series A round was led by Oak HC/FT, with participation from Norwest, .406 Ventures, Constellation Ventures, Y Combinator ...